Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: J07BB02

Fluad(A/Victoria/4897/2022 (H1N1)pdm09 like strain (A/Victoria/4897/2022, IVR-238);A/Croatia/10136RV/2023 (H3N2)-like strain (A/Croatia/10136RV/2023, X-425A);B/Austria/1359417/2021 like strain (B/Austria/1359417/2021, BVR-26))

Influenza, Human

Marketing Authorisation Holder: Seqirus Netherlands B.V.

EMA Authorisation: 15/11/2024

INN: influenza vaccine (surface antigen, inactivated, adjuvanted)

Indication

Prophylaxis of influenza in adults 50 years of age and older. Fluad should be used in accordance with official recommendations.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Fluad — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Ask about FluadCreate Free Account

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.